Cipla has received the Food and Drug Administration’s blessing for lanreotide injection 120 mg/0.5 ml, 90 mg/0.3 ml, 60 mg/0.2 ml, which is the generic of somatuline depot (lanreotide) injection.

Cipla shares fell sharply after the U.S. Food and Drug Administration (USFDA) flagged multiple compliance lapses at Pharmathen International SA, the third party contract manufacturer that supplies the ...

Cipla Ltd. on Thursday said production of one of its key drugs, Lanreotide injection, will be paused as its supply partner, Pharmathen International S.A., is currently engaged in remediation at its ...